Compare GAME & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GAME | INCR |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 47.4M |
| IPO Year | 2024 | 2021 |
| Metric | GAME | INCR |
|---|---|---|
| Price | $0.45 | $0.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.8M | 39.9K |
| Earning Date | 04-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,999,302.00 | N/A |
| Revenue This Year | $87.12 | $69.54 |
| Revenue Next Year | $21.14 | $41.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $0.68 |
| 52 Week High | $2.87 | $1.77 |
| Indicator | GAME | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 58.87 |
| Support Level | $0.41 | $0.86 |
| Resistance Level | $0.48 | $0.93 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 23.35 | 75.35 |
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.